Page 481 - medicina-integrativa_compress
P. 481

484     PARTE II,  SECCIÓN 7 TRASTORNOS GASTROINTESTINALES

               A possible explanation of the effect of diet on peptic ulceration.   73.  Soll AH: Medical treatment of peptic ulcer disease. JAMA 275:622,
               Gut 35:1557-1561, 1994.                             1996.
           53.  Frieri G, Pimpo MT, Palombieri A, et al: Polyunsaturated fatty   74.  Walsh JH, Peterson WL: The treatment of Helicobacter pylori
               acid dietary supplementation: An adjuvant approach to treatment   infection in the management of peptic ulcer disease. N Engl J Med
               of Helicobacter pylori infection. Nutr Res 20:907-916, 2000.  333:984, 1995.
           54.  Gaby AR: Helicobacter pylori eradication: Are there alternatives to  75.  Meyer JM, Silliman MP, Wang W, et al: Risk factors for Helicobacter
               antibiotics? Altern Med Rev 6:355-366, 2001.        pylori resistance in the United States: The surveillance of H. pylori
           55.  Sullivan A, Nord CE: Probiotics and gastrointestinal diseases.   Antimicrobial Resistance Partnership (SHARP) study, 1993-1999.
               J Intern Med 257:78-92, 2005.                       Ann Intern Med 136:13, 2002.
           56.  Probiotics in prevention of antibiotic associated diarrhea:   76.  Termanini B, Gibril F, Sutliff VE, et al: Effect of long-term gastric
               Meta-analysis, BMJ 324:1361-1367, 2002.             acid suppressive therapy on serum vitamin B 12 levels in patients with
           57.  Armuzzi A, Cremonini F, Bartolozzi F, et al: The effect of oral  Zollinger-Ellison syndrome. Am J Med 104:422-430, 1998.
               administration of Lactobacillus GG on antibiotic-associated  77.  Selway SA: Potential hazards of long-term acid suppression. Scand J
               gastrointestinal side-effects during Helicobacter pylori eradication  Gastroenterol Suppl 178:85-92, 1990.
               therapy. Aliment Pharmacol Ther 15:163-169, 2001.  78.  Mowat C, McColl KE: Alterations in intragastric nitrite and vitamin
           58.  Cremonini F, Di Caro S, Covino M, et al: Effect of different  C levels during acid inhibitory therapy. Best Pract Res Clin
               probiotic preparations on anti-Helicobacter pylori therapy–related  Gastroenterol 15:523-537, 2001.
               side effects: A parallel-group, triple-blind, placebo-controlled study.  79.  Laheij RJ, Sturkenboom MC, Hassing RJ, et al: Risk of community-
               Am J Gastroenterol 97:2744-2749, 2002.              acquired pneumonia and use of gastric acid-suppressive drugs.
           59.  Huwez FU, Thirlwell D, Cockayne A, et al: Mastic gum kills  JAMA 292:1955-1960, 2004.
               Helicobacter pylori. N Engl J Med 339:1946, 1998.  80.  Chan J, Briscomb D, Waterhouse E, Cannaby AM: An uncontrolled
           60.  Al-Said MS, Ageel AM, Parmar NS, Tariq M: Evaluation of mastic,   pilot study of HT7 for “stress.” Acupunct Med 20:74-77, 2002.
               a crude drug obtained from Pistacia lentiscus for gastric and  81.  Diehl DL: Acupuncture for gastrointestinal and hepatobiliary
               duodenal anti-ulcer activity. J Ethnopharmacol 15:271-278, 1986.  disorders. J Altern Complement Med 5:27-45, 1999.
           61.  Huwez FU, Al-Habbal MJ: Mastic in treatment of benign gastric  82.  Acupuncture: Review and Analysis of Reports on Controlled Clinical
               ulcers. Gastroenterol Jpn 21:273-274, 1986.         Trials (ISBN 92 4 15453 7). Geneva, Switzerland, World Health
           62.  Al-Habbal MJ, Al-Habbal Z, Huwez FU: A double-blind controlled  Organization, 2002.
               clinical trial of mastic and placebo in the treatment of duodenal  83.  Yongshun B: Clinical observations on the treatment of 98 cases
               ulcer. Clin Exp Pharmacol Physiol 11:541-544, 1984.  of peptic ulcer by massage. J Tradit Chin Med 13:50-51, 1993.
           63.  Kassir ZA: Endoscopic-controlled trial of four drug regimens in the  84.  Sotnikova EP: [Therapeutic use of aloe in experimental stomach
               treatment of chronic duodenal ulceration. Ir Med J 78:153-156, 1985.  ulcers]. Vrach Delo 6:71-74, 1984.
           64.  Morgan AG, Pacsoo C, McAdam WA, et al: Comparison between  85.  Saito H, Imanishi K, Okabe S, et al: [Effects of aloe extracts, aloctin
               cimetidine and Caved-S in the treatment of gastric ulceration, and  A, on gastric secretion and on experimental gastric lesions in rats].
               subsequent maintenance therapy. Gut 23:545-551, 1982.  Yakugaku Zasshi 109:335-339, 1989.
           65.  Morgan AG, Pacsoo C, McAdam WA: Maintenance therapy:   86.  Wang HH, Chung JG, Ho CC, et al: Aloe-emodin effects on
               A two-year comparison between Caved-S and cimetidine treatment  arylamine N-acetyltransferase activity in the bacterium Helicobacter
               in the prevention of symptomatic gastric ulcer recurrence. Gut  pylori. Planta Med 64:176-178, 1998.
               26:599-602, 1985.                               87.  Melzer J, Rosch W, Reichling J, et al: Meta-analysis: Phytotherapy
           66.  Morgan AG, Pacsoo C, McAdam WA: Comparison between  of functional dyspepsia with the herbal drug preparation STW 5
               ranitidine and ranitidine plus Caved-S in the treatment of gastric  (Iberogast). Aliment Pharmacol Ther 20:1279-1287, 2004.
               ulceration. Gut 26:1377-1379, 1985.             88.  Mahady GB, Pendland SL, Yun GS, et al: Ginger (Zingiber
           67.  Prucksunand C, Indrasukhsri B, Leethochawalit M, et al: Phase II  officinale Roscoe) and the gingerols inhibit the growth of Cag A +
               clinical trial on effect of the long turmeric (Curcuma longa Linn) on  strains of Helicobacter pylori. Anticancer Res 23(5A):3699-3702,
               healing of peptic ulcer. Southeast Asian J Trop Med Public Health  2003.
               32:208-215, 2001.                               89.  Yamahara J, Mochizuki M, Rong HQ, et al: The anti-ulcer effect
           68.  Swarnakar S, Ganguly K, Kundu P, et al: Curcumin regulates  in rats of ginger constituents. J Ethnopharmacol 23:299-304, 1988.
               expression and activity of matrix metalloproteinases 9 and 2 during  90.  al-Yahya MA, Rafatullah S, Mossa JS, et al: Gastroprotective activity
               prevention and healing of indomethacin-induced gastric ulcer. J Biol  of ginger Zingiber officinale rosc., in albino rats. Am J Chin Med
               Chem 280:9409-9415, 2005.                           17:51-56, 1989.
           69.  Cheney G: Rapid healing of peptic ulcers in patients receiving fresh  91.  Monographs on the medicinal uses of plant drugs. Exeter, UK,
               cabbage juice. Cal Med 70:10-14, 1949.              European Scientific Coop Phytother, 1997.
           70.  Doll R, Pygott F: Clinical trial of Robaden and of cabbage juice in  92.  Newall CA, Anderson LA, Philpson JD: Herbal Medicine: A Guide
               the treatment of gastric ulcer. Lancet 267:1200-1204, 1954.  for Healthcare Professionals. London, UK, Pharmaceutical Press,
           71.  Ford A, Delaney B, Forman, et al: Eradication therapy for peptic  1996.
               ulcer disease in Helicobacter pylori–positive patients. Cochrane  93.  Gruenwald J, Brendler T, Jaenicke C: PDR for Herbal Medicines.
               Database Syst Rev (3) www.cochrane.org, 2005.       Montvale, NJ, Medical Economics, 1998.
           72.  Freeman HJ: Disappearance of Helicobacter without antibiotics in   94.  Facts and Comparisons: The Review of Natural Products. St. Louis,
               12 patients with gastritis. Can J Gastoenterol 11:167-172, 1997.  MO, Wolters Kluwer, 1999.
   476   477   478   479   480   481   482   483   484   485   486